Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nadja Sailer"'
Autor:
Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde, Daniel Sommermeyer
Publikováno v:
Cancers, Vol 14, Iss 8, p 1998 (2022)
The hostile tumor microenvironment (TME) is a major challenge for the treatment of solid tumors with T-cell receptor (TCR)-modified T-cells (TCR-Ts), as it negatively influences T-cell efficacy, fitness, and persistence. These negative influences are
Externí odkaz:
https://doaj.org/article/3b9be45c48f644febde2084b9eeb2afe
Autor:
Elfriede Noessner, Daniel Sommermeyer, Christian Ellinger, Nadja Sailer, Melanie Salvermoser, Maria Gerget, Franziska Hasselmann, Monika Braun
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/51636d5c499d4f79be0bd958b356b0af
Autor:
Michael Esquerré, Audrey Holtzinger, Mélanie Pichery, Stefanie Pfaender, Saniye Yumlu, Mandy Richter, Delphine Betous, Oriane Bombarde, Mylène Gador, Nadja Sailer, Michael Paillasse, Loïc Ysebaert, Fabien Despas, Matthias Austen, Andreas Scheel, Markus Dangl
Publikováno v:
Cancer Research. 82:2749-2749
Cancer immunotherapy has transformed the oncology landscape and shown promising therapeutic results in the clinic but it is also clearly facing multiple limitations. So far, the focus of immunotherapies has mainly been on the modulation of T-cells. N
Autor:
Dolores J. Schendel, Elfriede Noessner, Nadja Sailer, Christian Ellinger, Maria Gerget, Daniel Sommermeyer, Monika Braun, Franziska Hasselmann, Melanie Salvermoser
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background The immunosuppressive tumor microenvironment (TME) of solid tumors negatively influences the efficacy and fitness of tumor-specific T cells and can render them non-functional. In this repressive tumor milieu, expression of inhibitory immun
Publikováno v:
Tumor Biology. 37:10665-10673
Elevated p130Cas (Crk-associated substrate) levels are found in aggressive breast tumors and are associated with poor prognosis and resistance to standard therapeutics in patients. p130Cas signals majorly through its phosphorylated substrate domain (
Autor:
Dolores J. Schendel, Nadja Sailer, Angelika J. Fischbeck, Sarah Thome, Elfriede Noessner, Patrik Kehler, Maria Gerget, Melanie Salvermoser, Maja Buerdek, Christian Ellinger, Luis Felipe Olguín-Contreras, Svenja Ruehland
Publikováno v:
Cancer Research. 80:3231-3231
Introduction: The use of cellular immunotherapies has led to impressive complete and durable clinical responses in patients with certain types of hematological cancers. However, positive clinical results in solid tumor indications are still rare and
Autor:
Paul S. Ulrich, Silvia Freudenthaler, Gertrude Cepl-Kaufmann, Birgit Peter, Markus Lehner, Caroline Herfert, Dominik Kepczynski, Eva Hanauska, Nadja Sailer, Tanita Müller, Dominique Piech, Margret Schild, Franziska Voss, Johannes H. Stigler, Joachim Eberhardt, Thorsten Lemanski, Rainer Weber, Arne Langer, Ksenia Lapina, Axel Schröter, Franz Josef Gangelmayer, Daniela Franke, Claudia Mayerhofer, Jana-Katharina Mende, Nora Gumpenberger, Matthias J. Pernerstorfer
Theaterzettel sind, sofern es sich um Ankündigungen berühmter Opern- und Theateraufführungen handelt, beliebte Ausstellungsstücke, und für die Spielplanforschung seit jeher eine bedeutende Quelle. In den letzten Jahren hat das Interesse an Theat
Publikováno v:
Theater-Zettel-Sammlungen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9b1694f6fbc21e16c9e5314b194a4fa
https://doi.org/10.2307/j.ctv6jmb66.10
https://doi.org/10.2307/j.ctv6jmb66.10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dolores J. Schendel, Silke Raffegerst, Judith Eckl, Nadja Sailer, Manon Weis, Barbara Mosetter, Christian Ellinger, Slavoljub Milosevic, Susanne Wilde, Bernhard Frankenberger, Giulia Longinotti, Carina Wehner
Publikováno v:
Journal for Immunotherapy of Cancer
In recent years, activation of the patient's immune system to defend against tumors was demonstrated to be a promising alternative strategy to classical cancer treatments. Dendritic cells (DCs) can present antigens on MHC-II and -I leading to the act